BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the appointment of Matthew Hall, PhD, as Director of Business Development. Matthew’s regional insights, gained from more than a decade as an insider in the Swiss biotech sector, combined with his expertise in AI and biology, make him a perfect fit for the BioLizard team. His unique profile and global network will further empower the company to expand and strengthen its presence in Switzerland and other key markets.
Liesbeth Ceelen, PhD, CEO of BioLizard, said: “We are delighted to welcome Matthew Hall to our team of ‘Lizards’ – as we like to call our employees – as Director of Business Development. His proven track record in biotech and strategic business development aligns perfectly with BioLizard’s mission to drive digital transformation across the life sciences sector. Deeply rooted in the Lausanne area and with an established regional and global network, he will be vital for our company as we build out our foothold at Biopôle, one of the largest biotech hubs in Switzerland and exciting pool for talent. With Matthew on board, we are very confident in our ability to further expand our presence in this crucial market and beyond.”
Matthew Hall, PhD, Director of Business Development at BioLizard
Matthew Hall, PhD, Director of Business Development at BioLizard, commented: “I’m excited to join BioLizard’s world-class team at the intersection of life sciences, bioinformatics, and AI/ML innovation. My focus will be on strategically expanding our business by fostering win-win partnerships that leverage our unique strengths in AI, data analysis and biology. I look forward to bridging client needs with our cutting-edge capabilities, transforming complex data into actionable insights. Next week, we will attend the Swiss Biotech Day, where I look forward to introducing BioLizard to my network. I am confident that we can bring great value to companies in the region, and I’m also excited about hosting our own events in the near future to understand and address our customer’s needs.”
Matthew brings extensive sector experience to BioLizard, having held leadership roles in multiple cutting-edge startups. As Head of Product Development at LAGOSTA, Matthew has played a key role in delivering a pharma/biotech compliant natural polymer to market. Previously, he was the Director of Strategic Partnerships at Distalmotion, a Lausanne-based surgical robotics company, where he supported a CHF 90 million Series E financing and drove the company’s scale-up efforts. As a Senior Project Leader AI at Distalmotion, he was responsible for evaluating and implementing data management, analytics, AI/ML, and simulator solutions. His experiencealso spans senior roles at QuartzBio as Senior Director Business Development, Data Integration AI strategy and notably as CEO, Co-founder, and Board member at SimplicityBio SA, where he guided the company to profitability and oversaw its successful acquisition by Precision for Medicine Ltd. Matthew earned his PhD in Molecular and Cellular Neurobiology from Université de Lausanne.
Read the press release
